Quantgene
Petra is responsible for the data management and the sample collection for Quantgene's feasibility study at the University Hospital Geneva. She also works closely with executive management to strategize and execute clinical trials.
This person is not in any offices
Quantgene
Medical technology now allows for cancer to be detected in a patient’s blood through cell-free DNA (cfDNA). Quantgene has developed a method for Deep Human Genome sequencing which allows us to see mutational patterns of disease down to a single molecule. This means diseases like cancer can be detected far earlier than ever before.